drugset / Trial / NCT06237049
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a single shot is safe and can help produce antibodies to defend the body against both SARS-CoV-2 (the virus that causes COVID-19) and influenza. Participants enrolled in this trial will be healthy adults, 50 years of age or older.
Timeline
- Start
- 2024-01-31
- Primary completion
- 2024-09-13
- Completion
- 2024-09-13